UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia

Neoplasia (New York, N.Y.), 2021-04, Vol.23 (4), p.361-374

2021

Volltextzugriff (PDF)

PD-L1 + macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma

Experimental hematology & oncology, 2023-03, Vol.12 (1), p.32-32, Article 32

2023

Volltextzugriff (PDF)

Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma

Oncoimmunology, 2021-01, Vol.10 (1), p.1928365-1928365

2021

Volltextzugriff (PDF)

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma

Journal of clinical oncology, 2022-01, Vol.40 (2), p.202-212

2022

Volltextzugriff (PDF)

Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma

Clinical cancer research, 2022-03, Vol.28 (5), p.972-983

2022

Volltextzugriff (PDF)

Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions

Cancers, 2021-11, Vol.13 (22), p.5627

2021

Volltextzugriff (PDF)

Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma

Clinical cancer research, 2020-11, Vol.26 (21), p.5579-5587

2020

Volltextzugriff (PDF)

Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up

Blood cancer journal (New York), 2020-05, Vol.10 (5), p.49-49, Article 49

2020

Volltextzugriff (PDF)

Management strategies and outcomes for very elderly patients with diffuse large B‐cell lymphoma

Cancer, 2016-10, Vol.122 (20), p.3145-3151

2016

Volltextzugriff (PDF)

Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma

Leukemia & lymphoma, 2021-01, Vol.62 (1), p.58-67

2021

Volltextzugriff (PDF)

‘Watch and Wait’ as Initial Management for Patients with Follicular Lymphomas: Still a Viable Strategy?

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2012-12, Vol.26 (6), p.363-376

Hagemeister, Fredrick B.

2012

Volltextzugriff (PDF)

Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma

Leukemia & lymphoma, 2018-04, Vol.59 (4), p.863-870

2018

Volltextzugriff (PDF)

Can we cure refractory Hodgkin’s lymphoma with transplantation?

Bone marrow transplantation (Basingstoke), 2021-01, Vol.56 (1), p.278-281

2021

Volltextzugriff (PDF)

Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL

Leukemia & lymphoma, 2020-05, Vol.61 (6), p.1380-1387

2020

Volltextzugriff (PDF)

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

Blood cancer journal (New York), 2022-02, Vol.12 (2), p.25-25, Article 25

2022

Volltextzugriff (PDF)

Maintenance and Consolidation Strategies in Non-Hodgkin’s Lymphoma: A Review of the Data

Current oncology reports, 2010-11, Vol.12 (6), p.395-401

Hagemeister, Fredrick B.

2010

Volltextzugriff (PDF)

Hodgkin's lymphoma in younger patients: lessons learned on the road to success

Oncology (Williston Park, N.Y.), 2007-04, Vol.21 (4), p.434

Hagemeister, Fredrick B

2007

Volltextzugriff (PDF)

NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, y, 18, and 21

Cancer research (Chicago, Ill.), 2003, Vol.63 (1), p.44-51

2003

Volltextzugriff (PDF)

Stem-cell transplant for Hodgkin's lymphoma: does choice of therapy prior to high-dose treatment matter?

Nature clinical practice. Oncology, 2005-07, Vol.2 (7), p.344-345

Hagemeister, Fredrick B

2005

Volltextzugriff (PDF)

Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma

Cancer research (Chicago, Ill.), 1988-10, Vol.48 (19), p.5557-5564

1988

Volltextzugriff (PDF)

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

Seminars in oncology, 2000-12, Vol.27 (6), p.37-41

2000

Volltextzugriff (PDF)

Small Noncleaved Cell Lymphoma in Adults Superior Results for Stages I–III Disease

Journal of clinical oncology, 1994-03, Vol.12 (3), p.646-646

1994

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(40)
Buchkapitel
(1)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia

PD-L1 + macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma

Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma

Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma

Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions

Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL

Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma

Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up

Management strategies and outcomes for very elderly patients with diffuse large B‐cell lymphoma

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study

Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma

Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

‘Watch and Wait’ as Initial Management for Patients with Follicular Lymphomas: Still a Viable Strategy?

Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma

Can we cure refractory Hodgkin’s lymphoma with transplantation?

Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

Maintenance and Consolidation Strategies in Non-Hodgkin’s Lymphoma: A Review of the Data

Hodgkin's lymphoma in younger patients: lessons learned on the road to success

NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, y, 18, and 21

Stem-cell transplant for Hodgkin's lymphoma: does choice of therapy prior to high-dose treatment matter?

Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

Small Noncleaved Cell Lymphoma in Adults Superior Results for Stages I–III Disease

Aktive Filter

Suchergebnisse filtern